Study of Safety & PK of Luspatercept (ACE-536) in Pediatric Participants With Beta (β)-Thalassemia

Clinical trial NCT04143724 · RECRUITING

Trial details

NCT number: NCT04143724
Sponsor: Celgene
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Beta-Thalassemia

Start date: 2019-11-07
Primary completion: 2028-01-31
Enrollment: 99

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.